Loading company…
ID 404999604 · FY 2023–2024 · 2 years
Subsidiary of შეზღუდული პასუხისმგებლობის საზოგადოება ისთჰორნ ქლინიქალ სერვისიზ ინ სიიი ლიმითიდი (100.0%)
კომპანიის ძირითად საქმიანობას წარმოადგენს სამედიცინო კვლევების წარმოება საქართველოში.
Bars are revenue on the left axis; lines are EBITDA and net margin on the right.
| Ratio | 2023 | 2024 |
|---|---|---|
| Margins | ||
| Gross Margin | 100.0% | 100.0% |
| EBITDA Margin | -6.6% | 6.1% |
| EBITDAR | -29 | 533 |
| EBITDAR Margin | -0.9% | 9.3% |
| EBIT Margin | -7.0% | 5.3% |
| Net Profit Margin | -7.0% | 7.9% |
| Operating Expense % of Sales | 106.6% | 93.9% |
| Returns | ||
| Return on Assets (ROA) | -98.7% | 86.2% |
| Return on Equity (ROE) | -154.6% | 86.6% |
| ROIC [EBIT / Invested Capital] | -196.7% | 83.4% |
| Leverage & debt balances | ||
| Debt-to-Assets | 0.0% | 0.0% |
| Debt-to-Equity | 0.00x | 0.00x |
| Debt-to-EBITDA | N/A | 0.00x |
| Equity-to-Assets | 63.8% | 99.5% |
| Net Debt | -29 | -162 |
| Cash & Equivalents | 29 | 162 |
| Total Debt | N/A | N/A |
| Liquidity & working capital | ||
| Current Ratio | N/A | 84.15x |
| Quick Ratio | N/A | 84.15x |
| Cash Ratio | N/A | 58.62x |
| Total Current Assets | 81 | 233 |
| Total Current Liabilities | N/A | 3 |
| Inventory | N/A | N/A |
| Trade Receivables | 3 | 6 |
| Trade Payables | 81 | 2 |
| Net Working Capital | 81 | 230 |
| Net Working Capital % of Revenue | 2.6% | 4.0% |
| Trade Working Capital | -78 | 4 |
| Trade Working Capital % of Revenue | -2.5% | 0.1% |
| Change in Trade Working Capital | N/A | 82 |
| Turnover & efficiency | ||
| Inventory Turnover | N/A | N/A |
| Days Inventory Outstanding (DIO) | N/A | N/A |
| Receivables Turnover | 1014.05x | 954.29x |
| Days Sales Outstanding (DSO) | 0.4 | 0.4 |
| Payables Turnover | N/A | N/A |
| Days Payable Outstanding (DPO) | N/A | N/A |
| Cash Conversion Cycle | 0.4 days | 0.4 days |
| Asset Turnover | 14.16x | 10.85x |
| Cash flow & dividends | ||
| Operating Cash Flow | 11 | 336 |
| Free Cash Flow (OCF − Capex proxy) | -136 | 181 |
| Cash Conversion (OCF / EBITDA) | N/A | 97.0% |
| Dividends Declared | N/A | N/A |
| Dividend Payout Ratio | N/A | N/A |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in ₾ '000. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Companies sharing this sub-sector, ranked by how close their latest revenue is to this one — not a curated comp set.
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Ownership & directors from companyinfo.ge (public corporate registry).